Overview
A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain.
Eligibility
Inclusion Criteria:
- Patient experiencing at least moderate pain (on the Categorical Pain Scale) for more than 3 months
- Patient with a BPI interference score ≥ 3 in at least 3 out of 7 dimensions
- Patient with a smartphone and an internet connection at the place of use
- Patient affiliated with a social security system or benefiting from such a system
Exclusion Criteria:
- Patient opposing participation in the study
- Patient with severe anxiety and/or depressive disorders (especially a suicidal risk)
- Patient presenting one or more barriers to the initiation of cognitive-behavioral therapy (significant social difficulties, low adherence to current care, insufficient memory or cognitive abilities, lack of time, lack of motivation...),
- Adult patient under legal protection measures (guardianship, legal safeguard, psychiatric care, or deprived of liberty by judicial or administrative decision)
